$468
3M Ago | 1M Ago | Current | |
Buy | 16 | 16 | 16 |
Outperform | 10 | 10 | 10 |
Hold | 8 | 10 | 10 |
Underperform | 1 | 1 | 1 |
Sell | 1 | 1 | 1 |
The latest share price target for Vertex Pharmaceuticals Incorporated (VRTX) is $513.97, offered by 38 analysts offering 12-month price forecasts.
Vertex Pharmaceuticals Incorporated (VRTX) has a maximum of 0.1 upside potential, based on 38 analysts offering 12-month price forecasts.
Based on 38 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX), 68.42% have a buy recommendation. Remaining 31.58% have either sell or hold recommendations.
The latest share price of Vertex Pharmaceuticals Incorporated (VRTX) is $468 as of 07/09/2024.
26 of total 38 analysts offering stock ratings for Vertex Pharmaceuticals Incorporated VRTX have recommended buy rating.